dibenzofuran-2-yl-(4-nitro-benzyl)-amine | 350016-94-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并呋喃
• 英文名称: dibenzofuran-2-yl-(4-nitro-benzyl)-amine
• 英文别名: N-[(4-nitrophenyl)methyl]dibenzofuran-2-amine
• CAS: 350016-94-3
• 化学式: C₁₉H₁₄N₂O₃
• 分子量: 318.332
• InChiKey: ADKATOLVAOGTSD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5
• 重原子数：
  24
• 可旋转键数：
  3
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.05
• 拓扑面积：
  71
• 氢给体数：
  1
• 氢受体数：
  4

文献信息

• Tricyclic compounds and method of treating herpes virus
  申请人：——

  公开号：US20030229073A1

  公开（公告）日：2003-12-11

  The present invention provides a compound of the formula (I) and pharmaceutically acceptable salts having useful antiviral activity against viruses of the herpes family. In said formula, X=O, (CH 2 ) m , S, SO, SO 2 , NH, NR 8 or a chemical bond; Y=O, (CH 2 ) m , S, SO, SO 2 , NH, NR 8 ; Z=NH, O, NR 8 , S, SO, SO 2 . The remaining substituents are described in the specification.

  本发明提供了一种公式(I)的化合物及其药学上可接受的盐，对于单纯疱疹病毒家族的病毒具有有用的抗病毒活性。在该式中，X=O、(CH2)m、S、SO、SO2、NH、NR8或化学键；Y=O、(CH2)m、S、SO、SO2、NH、NR8；Z=NH、O、NR8、S、SO、SO2。其余的取代基在说明书中描述。
• HNF4-alpha ANTAGONIST AND USE THEREOF
  申请人：NATIONAL CANCER CENTER

  公开号：US20160193238A1

  公开（公告）日：2016-07-07

  Provided is a hepatocyte nuclear factor 4 alpha (HNF4-α) antagonist and a use thereof. The HNF4-α antagonist selected in the present invention was confirmed to specifically bind to the ligand binding domain of HNF4-α, thereby inhibiting the activity of HNF4-α. The HNF4-α antagonist of the present invention can significantly reduce the expression of Wnt5a in a specific manner compared to that of the conventional known HNF4-α antagonists, and can also inhibit the growth of gastric cancer cells. Therefore, the HNF4-α antagonist of the present invention can not only be used as a pharmaceutical composition or a health functional food for preventing and treating cancer but can also be applied to a composition for treating or preventing diseases occurring due to the overexpression of HNF4-α.

  提供了一种肝细胞核因子4α（HNF4-α）拮抗剂及其用途。本发明选择的HNF4-α拮抗剂被确认能够特异性结合到HNF4-α的配体结合域，从而抑制HNF4-α的活性。与传统已知的HNF4-α拮抗剂相比，本发明的HNF4-α拮抗剂可以显著特异性地降低Wnt5a的表达，并且还能抑制胃癌细胞的生长。因此，本发明的HNF4-α拮抗剂不仅可以用作预防和治疗癌症的药物组合物或健康功能性食品，还可以应用于治疗或预防由于HNF4-α过度表达而导致的疾病的组合物。
• Process for producing phenylacetones
  申请人：UBE INDUSTRIES, LTD.

  公开号：EP0101223A2

  公开（公告）日：1984-02-22

  A phenylacetone or its derivative having the general formula (I): wherein X. Y, and Z are independently a hydrogen atom, a hydroxyl group, a halogen atom, a nitro group, an amino group, a lower alkyl group having 1 to 6 carbon atoms, a lower alkoxy group having 1 to 6 carbon atoms, or a benzyloxy group and any two substituents of X, Y, and Z may form, together with the benzene ring, a heterocycling ring having 5 to 7 members including 1 or 2 oxygen atoms is produced at a high yield and a high selectivity by reacting a 3-phenylpropylene or its derivative having the general formula (II): wherein X, Y and Z are as defined above, with an alkyl nitrite having the general formula (III):wherein R is an aliphatic, aromatic or alicyclic saturated or unsaturated hydrocarbon group in the presence of (a) water, (b) an alcohol, (c) a palladium catalyst, and (d) an optional amine or copper compound, or by reacting the above-mentioned 3-phenylpropylene or its derivative with the above-mentioned alkyl nitrite in the presence of (a) an alcohol, (b) a palladium catalyst and (c) an optional amine or copper compound to form 1-phemrl-2,2-dialkoxypropane or it derivative having the general formula (IV): wherein X, Y, Z and R are as defined above, followed by hydrolyzing the reaction product.

  具有通式(I)的苯丙酮或其衍生物： 其中 X.Y和Z独立地为氢原子、羟基、卤素原子、硝基、氨基、1至6个碳原子的低级烷基、1至6个碳原子的低级烷氧基或苄氧基，且X、Y和Z的任意两个取代基可与苯环一起形成一个具有5至7个成员（包括1或2个氧原子）的杂环： 其中 X、Y 和 Z 如上定义，与通式（III）的亚硝酸烷基酯反应：其中 R 为脂肪族、芳香族或脂环族饱和或不饱和烃基，在 (a) 水、(b) 醇、(c) 钯催化剂和 (d) 任选胺或铜化合物存在下反应、或在(a)醇、(b)钯催化剂和(c)任选胺或铜化合物存在下，使上述 3-苯基丙烯或其衍生物与上述亚硝酸烷基酯反应，生成通式为(IV)的 1-苯基-2,2-二烷氧基丙烷或其衍生物： 其中 X、Y、Z 和 R 如上定义，然后水解反应产物。
• Methods for forming combinatorial libraries using reductive amination
  申请人：NeoGenesis Pharmaceuticals, Inc.

  公开号：US20020115106A1

  公开（公告）日：2002-08-22

  The invention relates to methods for forming combinatorial libraries. The invention provides methods suitable for the rapid and convenient synthesis of very large combinatorial libraries of small organic molecules. In particular, the invention provides a method for forming combinatorial libraries combining amide, sulfonamide, or urea bond formation with reductive amination.

  本发明涉及形成组合文库的方法。本发明提供了适用于快速方便地合成超大型有机小分子组合库的方法。特别是，本发明提供了一种将酰胺、磺酰胺或脲键的形成与还原胺化结合起来形成组合库的方法。
• Working fluid composition for use in refrigeration system
  申请人：Kao Corporation

  公开号：EP0521650B1

  公开（公告）日：1997-08-13